Health Care/Hospital
Samsung Biologics, National OncoVenture, and Eutilex Obtain IND Approval from FDA
INCHEON, South Korea, Jan. 26, 2021 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) announced another successful Investigational New Drug (IND) clearance from the FDA for its client to begin clinical trials on a cancer immunotherapy, furthering the company's track record as a premiere CDO serv...
2021-01-27 08:26
6447
Biocytogen Subsidiary Eucure Biopharma Reports First Patient Enrolled in anti-CTLA4 Phase I Trial in China
BOSTON and BEIJING, Jan. 26, 2021 /PRNewswire/ -- Eucure Biopharma, a subsidiary of Biocytogen, announced the first patient enrollment for a Phase I clinical trial inChina to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of its anti-CTLA4 monoclonal antibody (YH001)...
2021-01-26 23:45
1534
Maypharm Announces New Product METOX on Times Square in New York
SEOUL, South Korea and NEW YORK, Jan. 26, 2021 /PRNewswire/ -- Maypharm
announces new botulinum toxin, METOX onJanuary 26, 2021. METOX is an effective
solution for smoothing any kind of wrinkles from moderate to severe, caused by
daily active facial movements.
2021-01-26 17:00
1905
Samsung Biologics Reports 66% Increase in 2020 Revenue Achieving "1 Trillion Won" Target Sales
INCHEON, South Korea, Jan. 26, 2021 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) reported its fourth quarter and full-year 2020 financial results indicating strong business performance, benefitting from increased sales across all plants and significant business agility and operating excelle...
2021-01-26 15:00
6698
I-Mab and MorphoSys Announce First Patient Dosed in U.S. Phase 1 Study of TJ210/MOR210 in Patients with Advanced Cancer
SHANGHAI, China and PLANEGG/MUNICH, Germany, Jan. 25, 2021 /PRNewswire/ -- I-Mab (Nasdaq: IMAB), and MorphoSys (FSE: MOR; Prime Standard Segment, MDAX & TecDAX; NASDAQ: MOR) today announced that the first patient has been dosed in a phase 1 dose escalation study to evaluate the safety, tolerabili...
2021-01-26 05:05
3696
BioNTech and Fosun Pharma Receive Authorization for Emergency Use in Hong Kong for COVID-19 Vaccine
MAINZ, Germany and SHANGHAI, China, 25 Jan. 2021 /PRNewswire/ -- BioNTech SE (Nasdaq: BNTX, "BioNTech" or "the Company") andShanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma" or "Group"; Stock Code: 600196.SH, 02196.HK) today announced that according to the Food and Health Bureau of ...
2021-01-26 01:18
6370
VolitionRx Limited Opens its New Manufacturing Facility in Belgium
AUSTIN, Texas, Jan. 25, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced the opening of "Silver One", its 10,000 square foot dedicated manufacturing facility located on the same science park as its Research and Development laboratory in Isnes,Belgium. Vol...
2021-01-25 21:45
8519
China Biologic Announces Extraordinary General Meeting of Shareholders
BEIJING, Jan. 25, 2021 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced that it has called an extraordinary general meeting of shareholders (the "EGM...
2021-01-25 21:44
9702
Dada Group secures necessities supply in Shijiazhuang during COVID-19 outbreak -- Chinese National TV Reported
SHANGHAI, Jan. 24, 2021 /PRNewswire/ -- Dada Group (Nasdaq: DADA) ("Dada" or the "Company"),China's leading local on-demand delivery and retail platform, is working with retailers and brands to provide safe, contactless on-demand delivery service inShijiazhuang, Hebei Province, to combat with the...
2021-01-25 11:29
4248
New Zealand team creates world-first innovation in the fight against Coronavirus
AUCKLAND, New Zealand, Jan. 22, 2021 /PRNewswire/ -- Datamine, a New Zealand based AI company, has createdëlarm: a personal early warning indicator for viral infection, includingCoronavirus. The ëlarm system overcomes what is arguably our greatest obstacle – viral spread by asymptomatic people wh...
2021-01-23 00:41
3263
Happiness Biotech Announces Financial Results for the Six Months Ended September 30, 2020 and Provides Guidance For the Whole Fiscal Year Ending March 31, 2021
NANPING, China, Jan. 22, 2021 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, today announced its unaudited financial results for the six months endedSeptember 30, 2020 and provided the guida...
2021-01-22 21:00
11516
DWHP Announces Extension of The Expiration Time of Its Tender Offer
PARK CITY, Utah, Jan. 22, 2021 /PRNewswire/ -- DW Healthcare Partners V, L.P. (" DWHP"), announced today that it is extending the expiration time of its previously announced cash tender offer (the "Tender Offer") in the Offer to Purchase datedDecember 21, 2020 ("Offer to Purchase") for all of the ...
2021-01-22 12:34
9847
Senhwa Announces the First Patient Enrolled in an Investigator Initiated Trial Of Silmitasertib as a Treatment for Patients with Severe COVID-19
TAIPEI and SAN DIEGO, Jan. 21, 2021 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company focused on next generation DNA Damage Response (DDR) therapeutics for the treatment of cancer, today announced that the first patient has enrolled into an investi...
2021-01-22 12:00
2168
Sasakawa Leprosy (Hansen's Disease) Initiative Generates Awareness in Buildup to World Leprosy Day 2021
TOKYO, Jan. 21, 2021 /PRNewswire/ -- With the approach of World Leprosy Day on
January 31, 2021, Sasakawa Leprosy (Hansen's Disease) Initiative has created a
number of opportunities to amplify the voices of persons affected by leprosy
and highlight the issues they face.
2021-01-21 22:00
1965
China Jo-Jo Drugstores Hosts the First Suppliers Conference in China
HANGZHOU, China, Jan. 21, 2021 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that the...
2021-01-21 21:30
7229
The 5th China Health Industry Development Forum Held in Panzhihua
PANZHIHUA, China, Jan. 20, 2021 /PRNewswire/ -- The 5th China Health Industry Development Forum, themed with "What Can the Health Industry Do for a Healthy China", was hosted in the Chinese city of Panzhihua onJanuary 18. At the forum that was organized by the Panzhihua Municipal People's Gover...
2021-01-20 20:02
1742
Jemincare initiates phase I clinical trial of anti-SARS-CoV-2 neutralizing antibody JMB2002
NANCHANG, China, Jan. 20, 2021 /PRNewswire/ -- On January 15, Jemincare Group, a Chinese pharmaceutical company, announced that it has initiated the phase I clinical trial of anti-SARS-CoV-2 neutralizing antibody (JMB2002). Preclinical studies of JMB2002 including pharmacology and toxicity were ...
2021-01-20 13:53
1607
Medibio Granted CE Mark Approval for MEBsleep
MINNEAPOLIS, Jan. 19, 2021 /PRNewswire/ -- Medibio Limited (MEB or the Company )(ASX: MEB)(OTCPINK: MDBIF), is pleased to announce that it has received CE Mark approval for its sleep staging software, MEBsleep. MEBsleep is a software-only medical device that analyses Electroencephalogram (EEG) ...
2021-01-19 21:06
5303
Gracell Biotechnologies Receives IND Approval from China NMPA for GC019F, a FasTCAR-Enabled CAR-T Therapy for the Treatment of Relapsed or Refractory Adult B-ALL
SUZHOU and SHANGHAI, China, Jan. 19, 2021 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced that the Nati...
2021-01-19 19:30
4198
Neurophth and AAVnerGene Enter Strategic AAV Capsids Partnership for Next-Generation Ophthalmic Gene Therapy
WUHAN, China and NEWARK, DE., Jan. 19, 2021 /PRNewswire/ -- Neurophth Therapeutics, Inc., a subsidiary of Wuhan Neurophth Biotechnology Ltd. gene therapy company (hereafter Neurophth), and AAVnerGene Inc., a specializing AAV technology company, today announced a strategic partnership to provide ...
2021-01-19 14:05
1844
Week's Top Stories
Most Reposted
Radisson Hotel Group accelerates growth in Indonesia with ANTA Hotel Bali Canggu, a member of Radisson Individuals
[Picked up by 313 media titles]
2025-12-10 10:00
HKSTP Makes Strategic Investment in Singapore Technology Company Vizzio; Forges Innovation Pact to Power Next-Generation AI and Smart City
[Picked up by 306 media titles]
2025-12-09 13:31
ARKANCE to Launch BIMLOGIQ - A New AI-Powered Extension to Its AEC Tech Stack Offering
[Picked up by 293 media titles]
2025-12-11 09:07
BeLive Studios, NewUnivers and ChopChop Systems Sign Memorandum of Understanding at ATF 2025
[Picked up by 288 media titles]
2025-12-08 11:00
2025 Guangzhou Design Week Opens: PHOMI Holdings Leads Tech Innovation in Architectural Aesthetics
[Picked up by 287 media titles]
2025-12-06 10:37
Most Read
Abu Dhabi signs agreements and explores opportunities to strengthen partnerships with India and Singapore
2025-12-06 09:00
4847
PAVS Achieves 18,037% YoY Revenue Increase in 2025 Interim Results
2025-12-05 21:45
4093
MALAYSIA REMAINS COMMITTED TO ACCELERATE TRANSFORMATIVE SOLUTIONS FOR A SUSTAINABLE AND INCLUSIVE FUTURE
2025-12-06 00:41
3950
Taipei City's Global Pass: A New Partner Channel for Global Startup Spaces
2025-12-06 01:06
3868
